Research and Markets: New Report Explores the Top 100 Best Pharma Outsourcing Service Providers in China and India

* Reuters is not responsible for the content in this press release.

Tue Jul 7, 2009 2:00am EDT

DUBLIN--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/research/7173f0/top_100_best_pharm) has
announced the addition of the "Top 100 Best Pharma Outsourcing Service Providers
in China and India" report to their offering. 

It has been well recognized that the global pharmaceutical industry is facing a
number of challenges at present. The difficulties the industry is experiencing
have forced all drug companies to change their current operation models. They
are now forced to pursue more efficient, cost-effective and productive ways to
conduct their operations, whether in R&D or manufacturing. The keys for them to
make a quick turnaround are to get drug discovered quicker, developed faster,
manufactured cheaper and marketed wider. 

Outsourcing has been proven to be one of the effective solutions for drug
companies to quickly turn the situation around as it provides them with the
desired efficiency, flexibility and agility. Among all emerging countries for
outsourcing, China and India have risen rapidly and become stars in the global
pharmaceutical outsourcing arena as both countries possess the unique
combination of low cost and quality service. The current global financial crisis
has also greatly enhanced the importance of these two countries to many drug
companies around the world who are vigorously seeking cost reduction. 

However, China and India each also possess their own, unique features and
characteristics, not only in the pharmaceutical-related industries but also in
almost every aspect of social structure. To many companies who are interested in
conducting outsourcing or investment in either country, it is always a challenge
to decide which country best fits their investment goals and which service
provider in the selected country best fits the requirements of their projects. 

The report, "Top 100 Best Pharma Outsourcing Service Providers in China and
India" (An appendix to the report "Comparison of Pharma Outsourcing between
China and India", which was separately published by JZMed, Inc.), compiled the
detailed company profiles of top 100 best outsourcing service providers in both
China and India. It equally selected, among a large pool of service vendors, 50
best players in each country. The report contains the most valuable and
desirable information sought by all pharma and biotech companies who are
interested in outsourcing to either China or India. 

After looking into the report, outsourcing companies will become comfortable
directly approaching the interesting service providers in the selected country.
The report will thus save them a preliminary trip to the country, which
generally includes a team of company executives, before they start contacting
the identified service providers. It will therefore save them a substantial
amount of cost and time. 

Selection criteria 

The top 50 best players in each country are carefully selected based on the
following criteria. Each player must: 

1) Be publicly recognized as a major player in their home country; or 2) Be one
of the largest in company size and service revenue in the industry sector of
their home country; or 3) Have long existing service history in the industry in
their home country; or 4) Be most active in their industry sector; or 5) Have
the broadest service scope and the strongest service capabilities in their
industry sector; or 6) Be the best in special technical areas even though the
company is not big and/or old enough in their industry sector. 

Categories Examined for Each Service Provider 

For each selected best service provider in each country, the report examined a
total of twelve technical categories (in addition to the detailed contact
information) to comprehensively measure their service capabilities. These
categories are considered the most important for an outsourcing company to know
when it looks for a service provider in either China or India. 

These examined categories include: 

1. Full description of each provider's service scope; 2. Analysis and comments
of their service features and strengths; 3. Evaluation of their service
capability levels according to international pharma outsourcing standard; 4.
Description of their facility and capacity; 5. In-house products that are ready
to offer; 6. The number of technical employees including the percentage of
senior level scientists; 7. Year the service company was founded; 8. Service
experience and customers each provider has served so far; 9. Latest annual
service revenues; 10. Background of service provider's founder(s) or current
executive(s) including their scientific/education merits and work experiences.
11. Overall rating of a service provider among all selected CROs and CMOs; 12.
Latest business move/development. 

Key Topics Covered:

Part I. Selection of Top 50 Best Service Providers in Each Country 

Part II. Company Profiles of Top 50 Best Chinese Outsourcing Service Providers 

Part III. Company Profiles of Top 50 Best Indian Outsourcing Service Providers 

Part IV. Classifications of All 100 Best Service Providers in China and India 

For more information visit
http://www.researchandmarkets.com/research/7173f0/top_100_best_pharm



Research and Markets
Laura Wood
Senior Manager
press@researchandmarkets.com
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716 

Copyright Business Wire 2009

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.